YAP may participate in the pathogenesis of AS through various mechanisms such as regulating inflammatory mediators, promoting osteoblast proliferation and differentiation, etc. In addition, some drugs and treatment strategies have been found to improve the symptoms and prognosis of autoimmune diseases by inhibiting the YAP signaling pathway [16, 17]. Here, YAP1 is linked to autoimmune disease.